John K. Chan, MD

Director of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center
John A. Kerner Distinguished Professorship in Gynecologic Oncology, UCSF

Phone: (415) 353-9600 (appts)
Box 1702, UCSF
San Francisco, CA 94143-1702

View on UCSF Profiles

Additional Websites

• Physician Referral Directory

Education

University of California, Berkeley, BA, 1987-91, Molecular Cell Biology
University of California, Los Angeles, MD, 1991-95, Medicine

Professional Experience

• 1999 - 2003
  Clinical Instructor, Department of Obstetrics and Gynecology, University of California, Irvine UC Irvine Medical Center
• 2003 - 2007
  Assistant Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine
• 2007 - present
  Assistant Professor, Director of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco
• 2007 - present
  Director of Division of Gynecologic Oncology, University of California, San Francisco, CA
• 2007 - present
  John A. Kerner Distinguished Professorship in Gynecologic Oncology

Honors & Awards

• 1995
  School of Medicine's "Highest Honor for Compassion and Academic Excellence," UCLA School of Medicine
• 1999
  National Cancer Institute / Gynecologic Cancer Foundation Research Fellowship (Honorary recipient)
• 1999
  Resident Teacher of the Year, UC Irvine School of Medicine
• 2000
  Clinical Research Fellowship Award, American Cancer Society
• 2002
  Reproductive Scientist Development Award, National Institute of Health
• 2004
  Outstanding Faculty Award, Dept. of Ob/Gyn, Stanford University
• 2005
  Reproductive Scientist Development Award, (phase II) National Institute of Health
• 2005
  Frank Lynch Essay Award, Pacific Coast Ob/Gyn Society
• 2005
  Ted Adams poster award, Pacific Coast Ob/Gyn Society
• 2006
  Investigator Award - Ovarian Cancer Immunotherapy - Stanford Cancer Center
• 2006
  Investigator Award - Ovarian Cancer Population-based Program - Stanford Cancer Center
• 2006
  Gynecologic Cancer Foundation (GCF) Research Award

Selected Publications

1. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8.
   View on PubMed
2. Cohen JG, Chan JK, Kapp DS. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5):572-9.
   View on PubMed
3. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31.
   View on PubMed
4. Cohen JG, Sherman AE, Kiet TK, Kapp DS, Osann K, Chen LM, O'Sullivan PS, Chan JK. Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol. 2012 Apr; 125(1):8-13.
   View on PubMed
5. Venkat P, Chen LM, Young-Lin N, Kiet TK, Young G, Amatori D, Dasverma B, Yu X, Kapp DS, Chan JK. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012 Apr; 125(1):237-40.
   View on PubMed
6. Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK. An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):199-204.
   View on PubMed
7. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 1; 29(7):832-8.
   View on PubMed
8. Monk BJ, Chan JK. American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts. Gynecol Oncol. 2010 Sep; 118(3):216-9.
   View on PubMed
9. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6.
   View on PubMed
10. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):301-6.
    View on PubMed
11. Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):307-11.
    View on PubMed
12. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61.
    View on PubMed
13. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43.
    View on PubMed
14. Havrilesky LJ, Maxwell GL, Chan JK, Myers ER. Cost effectiveness of a test to detect metastases for endometrial cancer. Gynecol Oncol. 2009 Mar; 112(3):526-30.
    View on PubMed
15. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5.
    View on PubMed
16. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008 Sep; 20(5):565-9.
    View on PubMed
17. Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008 Aug 1; 98(2):111-6.
    View on PubMed
18. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008 May 15; 112(10):2202-10.
    View on PubMed
19. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008 Jun; 109(3):370-6.
    View on PubMed
20. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 8; 98(7):1191-6.
    View on PubMed

View on UCSF Profiles